Publication:
Aberrant integration of Hepatitis B virus DNA promotes major restructuring of human hepatocellular carcinoma genome architecture.

dc.contributor.authorÁlvarez, Eva G
dc.contributor.authorDemeulemeester, Jonas
dc.contributor.authorOtero, Paula
dc.contributor.authorJolly, Clemency
dc.contributor.authorGarcía-Souto, Daniel
dc.contributor.authorPequeño-Valtierra, Ana
dc.contributor.authorZamora, Jorge
dc.contributor.authorTojo, Marta
dc.contributor.authorTemes, Javier
dc.contributor.authorBaez-Ortega, Adrian
dc.contributor.authorRodriguez-Martin, Bernardo
dc.contributor.authorOitaben, Ana
dc.contributor.authorBruzos, Alicia L
dc.contributor.authorMartínez-Fernández, Mónica
dc.contributor.authorHaase, Kerstin
dc.contributor.authorZumalave, Sonia
dc.contributor.authorAbal, Rosanna
dc.contributor.authorRodríguez-Castro, Jorge
dc.contributor.authorRodriguez-Casanova, Aitor
dc.contributor.authorDiaz-Lagares, Angel
dc.contributor.authorLi, Yilong
dc.contributor.authorRaine, Keiran M
dc.contributor.authorButler, Adam P
dc.contributor.authorOtero, Iago
dc.contributor.authorOno, Atsushi
dc.contributor.authorAikata, Hiroshi
dc.contributor.authorChayama, Kazuaki
dc.contributor.authorUeno, Masaki
dc.contributor.authorHayami, Shinya
dc.contributor.authorYamaue, Hiroki
dc.contributor.authorMaejima, Kazuhiro
dc.contributor.authorBlanco, Miguel G
dc.contributor.authorForns, Xavier
dc.contributor.authorRivas, Carmen
dc.contributor.authorRuiz-Bañobre, Juan
dc.contributor.authorPérez-Del-Pulgar, Sofía
dc.contributor.authorTorres-Ruiz, Raul
dc.contributor.authorRodriguez Perales, Sandra
dc.contributor.authorGaraigorta, Urtzi
dc.contributor.authorTubio, Jose M C
dc.contributor.authorCampbell, Peter J
dc.contributor.authorNakagawa, Hidewaki
dc.contributor.authorVan Loo, Peter
dc.contributor.funderEuropean Research Council (ERC)
dc.contributor.funderMINISTERIO DE CIENCIA Y COMPETITIVIDAD (ESPAÑA)
dc.contributor.funderXunta de Galicia
dc.contributor.funderFrancis Crick Institute
dc.contributor.funderCancer Research UK
dc.contributor.funderWellcome Trust
dc.contributor.funderASOCIACION ESPAÑOLA CONTRA EL CANCER
dc.contributor.funderEuropean Union (EU)
dc.contributor.funderInstituto de Salud Carlos III
dc.date.accessioned2024-12-13T13:23:57Z
dc.date.available2024-12-13T13:23:57Z
dc.date.issued2021-11-25
dc.descriptionWe thank the Supercomputing Centre of Galicia (CESGA) for providing complementary computational resources. J.M.C.T is supported by European Research Council Grant ERC-2016-STG - ERC Starting Grant 716290, and Ministerio de Ciencia, Innovacion y Universidades, Grants PGC2018-102245-B-100 and RYC-2014-14999. E.G.A. and P.O. are supported by Ministerio de Educacion Cultura y Deporte, fellowships FPU17/05396 and FPU18/03421, respectively. D.G-S. is supported by postdoctoral contract ED481B-2018/091 from Xunta de Galicia. B.R-M., A.O. and S.Z. are supported by Xunta de Galicia fellowships ED481A-2016/151, ED481A-2020/214 and ED481A-2018/199, respectively. A.L.B. is supported by Spanish Ministry of Economics and Competitiveness (MINECO) PhD fellowship BES-2016-078166. This work was supported by the Francis Crick Institute, which receives its core funding from Cancer Research UK (FC001202), the UK Medical Research Council (FC001202), and the Wellcome Trust (FC001202). For the purpose of Open Access, the authors have applied a CC BY public copyright licence to any Author Accepted Manuscript version arising from this submission. This project was enabled through access to the MRC eMedLab Medical Bioinformatics infrastructure, supported by the Medical Research Council (grant number MR/L016311/1). M.M-F. is funded by the Spanish Association for Cancer Research (AECC, grant207mart). S.R-P. is supported by grants from the Spanish National Research and Development Plan, Instituto de Salud Carlos III, and FEDER (PI17/02303, PI20/01837 and DTS19/00111); AEI/MICIU EXPLORA Project BIO2017-91272-EXP and AECC_Lab_2020 Project (Asociacion Espanola Contra el Cancer). X.F. and S.P-P. are supported by grants from the Instituto de Salud Carlos III through the Spanish National Plan for Scientific and Technical Research and Innovation (PI18/00079 and PI19/00036, respectively), co-funded by the European Regional Development Fund (ERDF), and from Secretaria d'Universitats i Recerca del Departament d'Economia i Coneixement (grant 2017_SGR_1753) and CERCA Programme/ Generalitat de Catalunya. J.R-B. is supported by a Rio Hortega Fellowship from the Institute of Health Carlos III (CM19/00087) and a 2020 TTD Research Grant from the Spanish Cooperative Group for the Teatment of Digestive Tumours (TTD). J.D. is a postdoctoral fellow of the Research Foundation - Flanders (FWO). U.G. is supported by Ministerio de Ciencia e Innovacion grants PID2020-118970RB-100, SAF2016-75169-R and RYC-2014-15805. P.V.L. is a Winton Group Leader in recognition of the Winton Charitable Foundation's support towards the establishment of The Francis Crick Institute. A.D-L. is supported by a Juan Rodes contract from ISCIII (JR17/00016). A.R-C. is supported by GAIN and Xunta de Galicia (IN853B 2018/03).
dc.description.abstractMost cancers are characterized by the somatic acquisition of genomic rearrangements during tumour evolution that eventually drive the oncogenesis. Here, using multiplatform sequencing technologies, we identify and characterize a remarkable mutational mechanism in human hepatocellular carcinoma caused by Hepatitis B virus, by which DNA molecules from the virus are inserted into the tumour genome causing dramatic changes in its configuration, including non-homologous chromosomal fusions, dicentric chromosomes and megabase-size telomeric deletions. This aberrant mutational mechanism, present in at least 8% of all HCC tumours, can provide the driver rearrangements that a cancer clone requires to survive and grow, including loss of relevant tumour suppressor genes. Most of these events are clonal and occur early during liver cancer evolution. Real-time timing estimation reveals some HBV-mediated rearrangements occur as early as two decades before cancer diagnosis. Overall, these data underscore the importance of characterising liver cancer genomes for patterns of HBV integration.
dc.description.peerreviewed
dc.format.number1
dc.format.page6910
dc.format.volume12
dc.identifier.citationNat Commun . 2021 Nov 25;12(1):6910.
dc.identifier.journalNature Communications
dc.identifier.pubmedID34824211
dc.identifier.urihttps://hdl.handle.net/20.500.12105/25879
dc.language.isoeng
dc.publisherNature Publishing Group
dc.relation.projectIDinfo:eu-repo/grantAgreement/MINECO//RYC-2014-15805/ES/RYC-2014-15805/
dc.relation.projectIDinfo:eu-repo/grantAgreement/AEI/Plan Estatal de Investigación Científica y Técnica y de Innovación 2017-2020/PID2020-118970RB-I00/ES/ESTUDIO DE LOS DETERMINANTES VIRALES Y CELULARES RESPONSABLES DE LA INTEGRACION DEL DNA DEL VIRUS DE LA HEPATITIS B /
dc.relation.projectIDinfo:eu-repo/grantAgreement/ISCIII/Plan Estatal de Investigación Científica y Técnica y de Innovación 2017-2020 (ISCIII)/PI19%2F00036/ES/INTERACCION ENTRE EL VHB, EL VHD Y LOS FACTORES DEL HUESPED: IMPACTO EN LA PROGRESION DE LA ENFERMEDAD HEPATICA/
dc.relation.projectIDinfo:eu-repo/grantAgreement/ISCIII/Plan Estatal de Investigación Científica y Técnica y de Innovación 2013-2016 (ISCIII)/PI18%2F00079/ES/ESTUDIO DE LA DISFUNCION DE LA RESPUESTA INMUNE ADAPTATIVA PERIFERICA E INTRAHEPATICA EN LAS DIFERENTES FASES DE LA INFECCION CRONICA POR EL VIRUS DE LA HEPATITIS B/
dc.relation.projectIDinfo:eu-repo/grantAgreement/ISCIII/Plan Estatal de Investigación Científica y Técnica y de Innovación 2013-2016 (ISCIII)/PI17%2F02303/ES/ESTUDIO DEL PAPEL DE LAS MODIFICACIONES EPIGENETICAS EN EL DESARROLLO DEL SARCOMA DE EWING: SCREENING MASIVO DE GENES EPIGENETICOS MEDIANTE LIBRERIAS CRISPR EN CELULAS T(11;22)+HUMANAS/
dc.relation.projectIDinfo:eu-repo/grantAgreement/ISCIII/Plan Estatal de Investigación Científica y Técnica y de Innovación 2017-2020 (ISCIII)/PI20%2F01837/ES/USO DEL SISTEMA CRISPR%2FCAS13 PARA EL DIAGNOSTICO E INHIBICION DE ONCOGENES DE FUSION/
dc.relation.projectIDinfo:eu-repo/grantAgreement/EC/H2020/716290/EU
dc.relation.projectIDinfo:eu-repo/grantAgreement/MINECO//RYC-2014-14999/ES/RYC-2014-14999/
dc.relation.publisherversionhttp://www.doi.org.10.1038/s41467-021-26805-8
dc.repisalud.institucionCNIO
dc.repisalud.orgCNIOCNIO::Unidades técnicas::Unidad de Citogenética Molecular
dc.rights.accessRightsopen access
dc.rights.licenseAttribution-NonCommercial-NoDerivatives 4.0 International
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.subjectREAD ALIGNMENT
dc.subjectLIVER
dc.subjectTRANSLOCATION
dc.subjectCHROMOSOMES
dc.subjectASSOCIATION
dc.subjectMUTATIONS
dc.titleAberrant integration of Hepatitis B virus DNA promotes major restructuring of human hepatocellular carcinoma genome architecture.
dc.typeresearch article
dc.type.hasVersionVoR
dspace.entity.typePublication
relation.isAuthorOfPublication6c54780c-068e-41c2-9f5d-ec932cd52d04
relation.isAuthorOfPublicationcac6c6e2-06a9-4548-b216-3d7d32ed6b6e
relation.isAuthorOfPublication.latestForDiscoverycac6c6e2-06a9-4548-b216-3d7d32ed6b6e
relation.isFunderOfPublication7d739953-4b68-4675-b5bb-387a9ab74b66
relation.isFunderOfPublication.latestForDiscovery7d739953-4b68-4675-b5bb-387a9ab74b66

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
AberrantintegrationofHepatitisB-2021.pdf
Size:
3.45 MB
Format:
Adobe Portable Document Format